ANI PHARMACEUTICALS INC. - COMMON STOCK
62.86
13-March-25 09:20:58
15 minutes delayed
Stocks
-0.40
-0.63%
Today's range
62.50 - 63.33
ISIN
N/A
Source
NASDAQ
-
13 Aug 2024 15:05:27 By Nasdaq GlobeNewswire
-
ANI Pharmaceuticals, Inc. Prices Upsized $275.0 Million Convertible Senior Notes Offering
07 Aug 2024 20:44:18 By Nasdaq GlobeNewswire
-
ANI Pharmaceuticals, Inc. Announces Proposed Convertible Senior Notes Offering
07 Aug 2024 06:00:55 By Nasdaq GlobeNewswire
-
ANI Pharmaceuticals Reports Second Quarter 2024 Financial Results and Raises 2024 Guidance
06 Aug 2024 05:50:00 By Nasdaq GlobeNewswire
-
31 Jul 2024 06:00:00 By Nasdaq GlobeNewswire
-
ANI Pharmaceuticals Announces the FDA Approval and Launch of L-Glutamine Oral Powder
15 Jul 2024 06:00:00 By Nasdaq GlobeNewswire
-
ANI Pharmaceuticals Announces the FDA Approval and Launch of Naproxen Delayed-Release Tablets, USP
02 Jul 2024 06:00:00 By Nasdaq GlobeNewswire
-
25 Jun 2024 06:00:02 By Nasdaq GlobeNewswire
-
ANI Pharmaceuticals to Further Expand Rare Disease Business through Acquisition of Alimera Sciences
24 Jun 2024 05:50:44 By Nasdaq GlobeNewswire
-
ANI Pharmaceuticals to Present at the 2024 Jefferies Global Healthcare Conference
29 May 2024 15:30:00 By Nasdaq GlobeNewswire
-
ANI Pharmaceuticals Announces the Launch of Kionex® Suspension
20 May 2024 05:50:00 By Nasdaq GlobeNewswire
-
ANI Pharmaceuticals Reports Record First Quarter 2024 Financial Results and Reiterates 2024 Guidance
10 May 2024 05:50:00 By Nasdaq GlobeNewswire
-
ANI Pharmaceuticals to Participate at Two Upcoming Healthcare Conferences
01 May 2024 15:30:00 By Nasdaq GlobeNewswire
-
ANI Pharmaceuticals to Discuss First Quarter 2024 Financial Results on May 10, 2024, at 8:30 a.m. ET
18 Apr 2024 15:05:00 By Nasdaq GlobeNewswire
-
ANI Pharmaceuticals Announces the Launch of Baclofen Oral Suspension
09 Apr 2024 05:50:00 By Nasdaq GlobeNewswire
-
ANI Pharmaceuticals Recognizes Sarcoidosis Awareness Month and Patients Living with Sarcoidosis
04 Apr 2024 05:50:00 By Nasdaq GlobeNewswire
-
ANI Pharmaceuticals to Participate at the Piper Sandler Spring Biopharma Symposium
03 Apr 2024 05:50:00 By Nasdaq GlobeNewswire
-
ANI Pharmaceuticals Announces the Launch of Levofloxacin Oral Solution, USP
27 Mar 2024 05:50:00 By Nasdaq GlobeNewswire
-
29 Feb 2024 05:50:01 By Nasdaq GlobeNewswire
-
ANI Pharmaceuticals to Present at the Leerink Partners Global Biopharma Conference
20 Feb 2024 05:50:00 By Nasdaq GlobeNewswire